Respiratory failure & ventilation
Should Transport Ventilators Be Used in Times of Crisis? The Use of Emergency Authorized Nonconventional Ventilators Is Associated With Mortality Among Patients With COVID-19 Acute Respiratory Distress Syndrome*
Main findingResult — go to the resultOdds ratio 1.41 95% CI 1.07–1.86Authors' conclusion
Use of NCV was associated with increased mortality among patients with COVID-19 ARDS.
Study context
- Population
- Patients intubated for COVID-19 acute respiratory distress syndrome (ARDS), single healthcare system in New York, March 1–April 30, 2020
- Exposure
- Exclusive nonconventional ventilator use vs remainder of sample
- Outcome
- In-hospital mortality
- Follow-up
- 28 days
Methodological detailsmulticentre, single healthcare system
- Multicentre
- Single healthcare system
Main finding
As reported in the abstract
Odds ratio
1.41
95% CI 1.07–1.86
NCV vs Control
OR 1.41 (95% CI 1.07–1.86)
Observational data: associations, not effects.
Further findings
28-day in-hospital mortality (propensity score-matched analysis) · propensity score-matched subset
P = 0.02
Original publication
Should Transport Ventilators Be Used in Times of Crisis? The Use of Emergency Authorized Nonconventional Ventilators Is Associated With Mortality Among Patients With COVID-19 Acute Respiratory Distress Syndrome*. Crit Care Med. Published 2 April 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →